Tabula Rasa HealthCare Inc
NASDAQ:TRHC
Intrinsic Value
Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. [ Read More ]
The intrinsic value of one
TRHC
stock under the Base Case scenario is
16.55
USD.
Compared to the current market price of 10.5 USD,
Tabula Rasa HealthCare Inc
is
Undervalued by 37%.
Tabula Rasa HealthCare Inc's market capitalization is 284.1m USD.
TRHC stock price is 10.5 USD.
TRHC stock price (10.5 USD) is 37% less than its Intrinsic Value (16.55 USD).
TRHC stock price (10.5 USD) is 56% less than its Relative Value (23.85 USD). Open Relative Valuation
TRHC has upside potential of 0% compared to the average analyst price target.
Open Wall St Estimates
TRHC's ROIC (Return on Invested Capital) has increased in the last 3 years from -15% to -14%, and is approaching profitability.
TRHC's Revenue has been growing by 4% per year for the last 3 years.
TRHC's Revenue has grown by an exceptional 22% over the past 12 months.
TRHC's Revenue is forecast to grow at a rate of 18% per year over the next 3 years.
TRHC's short-term assets (147m USD) exceed its short-term liabilties (94m USD).
TRHC has positive Gross Profit for the last twelve months.
TRHC's long-term liabilties (434m USD) exceed its long-term assets (356m USD).
TRHC's ROE (Return on Equity) has significantly increased in the last 3 years from -65% to 225%.
TRHC's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -14%.
TRHC has negative Operating Income for the last twelve months.
TRHC has negative Net Income for the last twelve months.
TRHC's ROE (Return on Equity) for the past 12 months is very high and is equal to 225%.
TRHC has negative Free Cash Flow for the last twelve months.
TRHC has positive Net Debt. This means that the company has more debt (321m USD) than cash and short-term investments (63m USD).
TRHC has negative three-year average ROIC (Return on Invested Capital): -12%. The company is not efficient at using invested capital to generate operating income.
TRHC has very high three-year average ROE (Return on Equity): 1 730%. The company is very efficient at transforming stockholders' equity into net income.
TRHC's D/E (Debt to Equity) is very low and is equal to -4.12.
TRHC's Altman Z-Score is very low and is equal to -0.96.
TRHC doesn't generate enough operating income (-51m USD) to safely cover interest payments on its debt (6m USD).
Valuation Backtest
Tabula Rasa HealthCare Inc
Run backtest to discover the historical profit from buying and selling
TRHC
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Tabula Rasa HealthCare Inc
Balance Sheet Decomposition
Tabula Rasa HealthCare Inc
| Current Assets | 146.7m |
| Cash & Short-Term Investments | 62.8m |
| Receivables | 56.9m |
| Other Current Assets | 26.9m |
| Non-Current Assets | 209.3m |
| PP&E | 19.5m |
| Intangibles | 183.5m |
| Other Non-Current Assets | 6.2m |
| Current Liabilities | 93.7m |
| Accounts Payable | 20.6m |
| Accrued Liabilities | 25.8m |
| Other Current Liabilities | 47.3m |
| Non-Current Liabilities | 340.3m |
| Long-Term Debt | 321.3m |
| Other Non-Current Liabilities | 19m |
Earnings Waterfall
Tabula Rasa HealthCare Inc
|
Revenue
|
338.1m
USD
|
|
Cost of Revenue
|
-258.3m
USD
|
|
Gross Profit
|
79.8m
USD
|
|
Operating Expenses
|
-131.1m
USD
|
|
Operating Income
|
-51.3m
USD
|
|
Other Expenses
|
-44.2m
USD
|
|
Net Income
|
-95.5m
USD
|
Free Cash Flow Analysis
Tabula Rasa HealthCare Inc
What is Free Cash Flow?
TRHC Profitability Score
Profitability Due Diligence
Tabula Rasa HealthCare Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Tabula Rasa HealthCare Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
TRHC Solvency Score
Solvency Due Diligence
Tabula Rasa HealthCare Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Score
Tabula Rasa HealthCare Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TRHC Price Targets Summary
Tabula Rasa HealthCare Inc
According to Wall Street analysts, the average 1-year price target for
TRHC
is 10.5 USD
.
Ownership
TRHC Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
TRHC Price
Tabula Rasa HealthCare Inc
| Average Annual Return | -27.13% |
| Standard Deviation of Annual Returns | 30.89% |
| Max Drawdown | -97% |
| Market Capitalization | 284.1m USD |
| Shares Outstanding | 27 050 800 |
| Percentage of Shares Shorted | 3.9% |
Company Profile
Tabula Rasa HealthCare Inc
Country
Industry
Market Cap
Dividend Yield
Description
Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. The company is headquartered in Moorestown, New Jersey and currently employs 1,602 full-time employees. The company went IPO on 2016-09-29. The Company’s segments include CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. The company accesses the market through a number of different service lines and brands, including CareKinesis, Capstone Risk Adjustment Services, CareVention Consulting, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides its clients, primarily health plans, and retail pharmacies. The company provides cloud-based patient engagement software and services and full-service clinical pharmacy programs. The company provides medication therapy management (MTM) software and services for Medicare, Medicaid, and commercial health plans.
Contact
IPO
Employees
Officers
The intrinsic value of one
TRHC
stock under the Base Case scenario is
16.55
USD.
Compared to the current market price of 10.5 USD,
Tabula Rasa HealthCare Inc
is
Undervalued by 37%.
You don't have any saved screeners yet
